Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Steven G. DuBois"'
Clinical characteristics and outcomes of pediatric patients with desmoplastic small round cell tumor
Publikováno v:
Rare Tumors, Vol 8, Iss 1 (2016)
Desmoplastic small round cell tumor (DSRCT) is a rare malignancy that typically affects pediatric and young adult patients. There are limited data on the clinical features of pediatric DSRCT. We selected patients aged 0-21 years reported to the Surve
Externí odkaz:
https://doaj.org/article/b2d6a9aa2c124b7682aa37584ebacb6f
Autor:
David S. Shulman, Sarah B. Whittle, Didier Surdez, Kelly M. Bailey, Enrique de Álava, Jason T. Yustein, Adam Shlien, Masanori Hayashi, Alexander J. R. Bishop, Brian D. Crompton, Steven G. DuBois, Neerav Shukla, Patrick J. Leavey, Stephen L. Lessnick, Heinrich Kovar, Olivier Delattre, Thomas G. P. Grünewald, Cristina R. Antonescu, Ryan D. Roberts, Jeffrey A. Toretsky, Franck Tirode, Richard Gorlick, Katherine A. Janeway, Damon Reed, Elizabeth R. Lawlor, Patrick J. Grohar
Publikováno v:
npj Precision Oncology. 6
The advent of dose intensified interval compressed therapy has improved event-free survival for patients with localized Ewing sarcoma (EwS) to 78% at 5 years. However, nearly a quarter of patients with localized tumors and 60-80% of patients with met
Autor:
Alberto S. Pappo, John T. Lucas, Shane A. Lloyd, Christopher L. Tinkle, Steve Braunstein, Charu Singh, Yian Guo, Matthew J. Krasin, Yimei Li, Steven G. DuBois, Stephanie A. Terezakis, Daphne A. Haas-Kogan
Publikováno v:
Int J Radiat Oncol Biol Phys
International journal of radiation oncology, biology, physics, vol 109, iss 5
International journal of radiation oncology, biology, physics, vol 109, iss 5
Purpose The use of stereotactic body radiation therapy (SBRT) in pediatric patients has been underreported. We reviewed practice patterns, outcomes, and toxicity of SBRT in this population. Methods and Materials In this multi-institutional study, 55
Autor:
Steven G. DuBois, Dinesh Rakheja, Allen Buxton, Lisa A. Teot, Julia Glade-Bender, Katherine A. Janeway, Mark Krailo, Richard Gorlick, Stephen L. Lessnick, Brian D. Crompton
Publikováno v:
Arch Pathol Lab Med
Context.— Molecular diagnostics play an increasing role in the diagnosis of Ewing sarcoma. The type of molecular testing used in clinical practice has been poorly described. Objective.— To describe patterns of translocation testing for newly diag
Autor:
Abigail Ward, Katherine A. Janeway, Junne Kamihara, Kris Ann P. Schultz, Catherine Clinton, Jonathan A. Nowak, Elizabeth Mullen, Steven G. DuBois, Deirdre Reidy, Sara O. Vargas, David S. Shulman, William D. Foulkes, Dinesh Rakheja, Micheál Breen, Vera A. Paulson, Alanna J. Church, Michelle Schoettler, Jaclyn Schienda, Theodore W. Laetsch, Paul A. Meyers, Daniel A. Weiser, R. Seth Pinches
Publikováno v:
Modern Pathology. 33:1910-1921
The spectrum of neoplasms associated with DICER1 variants continues to expand, with the recent addition of primary “DICER1-associated central nervous system sarcoma” (DCS). DCS is a high-grade malignancy predominantly affecting pediatric patients
Autor:
Mark Krailo, Douglas S. Hawkins, Katherine A. Janeway, Steven G. DuBois, Patrick J. Leavey, Allen Buxton, Paul J. Chuba, Richard B. Womer, Nadia N. Laack, Leo Mascarenhas, Helen Nadel, Daniel J. Indelicato, Neyssa Marina, Dian Wang, Atif A. Ahmed, Damon R. Reed, Ken Brown, Bruce R. Pawel, Mark L. Bernstein, R. Lor Randall, Holcombe E. Grier, Richard Gorlick, G. Douglas Letson, Alexis Maciej
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 39, iss 36
J Clin Oncol
J Clin Oncol
PURPOSE The primary aim of this phase III randomized trial was to test whether the addition of vincristine, topotecan, and cyclophosphamide (VTC) to interval compressed chemotherapy improved survival outcomes for patients with previously untreated no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eabada51e1a7145dd6bead1da83d3d8e
https://escholarship.org/uc/item/83q6v33g
https://escholarship.org/uc/item/83q6v33g
Autor:
Anderson B. Collier, Mark Krailo, Steven G. DuBois, Lisa Bomgaars, Mark L. Bernstein, Damon R. Reed, Ha Dang, Richard Gorlick, Katherine A. Janeway, Douglas S. Hawkins
Publikováno v:
Pediatr Blood Cancer
Seven Children’s Oncology Group phase 2 trials for patients with relapsed/progressive solid tumors were analyzed to estimate the event-free survival (EFS) for relapsed/progressive Ewing sarcoma. One hundred twenty-eight Ewing sarcoma patients were
Autor:
Julie A. Bradley, Rachel Leeman, Robert Ruiz, Matteo Trucco, Steven G. DuBois, Kerice Pinkney, Christopher A. French
Publikováno v:
J Pediatr Hematol Oncol
Nuclear protein in testis carcinoma is a rare and highly aggressive carcinoma associated with a 70% mortality rate 1 year from diagnosis and a median survival of only 6.5 months. No established treatment protocol exists, although some success has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f88290b9dce1d8dc31bdc014fe89652f
https://europepmc.org/articles/PMC8887700/
https://europepmc.org/articles/PMC8887700/
Autor:
Thomas G. P. Grunewald, Jeffrey A. Toretsky, Sebastian Bauer, Wolfgang Hartmann, Stefan K. Zöllner, Volker Vieth, Uta Dirksen, Yasmin Uhlenbruch, Beate Timmermann, Enrique de Álava, Stéphane Collaud, Heinrich Kovar, James F. Amatruda, Markus Metzler, David S. Shulman, Jendrik Hardes, Arne Streitbürger, Steven G. DuBois
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 1685, p 1685 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine
Ewing sarcoma, a highly aggressive bone and soft-tissue cancer, is considered a prime example of the paradigms of a translocation-positive sarcoma: a genetically rather simple disease with a specific and neomorphic-potential therapeutic target, whose
Autor:
Andrzej Niemierko, Steven G. DuBois, Kevin X. Liu, Nayan Lamba, Daphne A. Haas-Kogan, William L. Hwang
Publikováno v:
Cancer. 125:1357-1364
Background Up to one-third of patients with localized Ewing sarcoma (ES) develop recurrent disease, but current biomarkers do not accurately identify this high-risk group. Therefore, the objective of this study was to determine the utility of mutatio